跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Novaxone - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Novaxone
Approved
STANDARD
Novaxone
Sance Laboratories Private Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
9200fa9992eb79ab
Company
Sance Laboratories Private Limited
Type
Standard
Approval Details
Approval Id
9200fa9992eb79ab
Drug Approval Philippines Name
Novaxone
Product Name
Novaxone
Registration Number
DRP-5965
Brand Name
Novaxone
Generic Name
Ceftriaxone (as Sodium)
Dosage Form
Powder For Injection (IM/IV)
Dosage Strength
1g
Manufacturer
Sance Laboratories Private Limited
Importer
Medinova Pharmaceutical Inc.
Distributor
Medinova Pharmaceutical Inc.
Issuance Date
24 January 2025
Expiry Date
29 January 2030
Pharmacologic Category
Antibacterial (Cephalosporin)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
9200fa9992eb79ab
Type
Standard
Back to Philippines FDA Approvals